N/A
|
BAZ2-ICR(CAT: I004082) is a potent, selective, and cell-active BAZ2A/B bromodomain inhibitor, with IC50 values of 130 nM (BAZ2A) and 180 nM (BAZ2B), and Kd values of 109 nM and 170 nM, respectively. It exhibits 10–15-fold
|
Buy from Supplier |
89
|
Tocris
baz2 icr Baz2 Icr, supplied by Tocris, used in various techniques. Bioz Stars score: 89/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/baz2+icr/BAZ2-ICR/bio_rxiv__2021__12__21__473688-183-21-22 Average 89 stars, based on 1 article reviews
baz2 icr - by Bioz Stars,
2026-09
89/100 stars
|
Buy from Supplier |
N/A
|
BAZ2-ICR is a potent, selective, cell active and orally active BAZ2A/B bromodomains inhibitor with IC50s of 130 nM and 180 nM, and Kds of 109 nM and 170 nM, respectively. BAZ2-ICR shows 10-15-fold selectivity for
|
Buy from Supplier |
N/A
|
BAZ2-ICR is a bromodomain inhibitor with IC50 of 130 nM for BAZ2A and IC50 of 180 nM for BAZ2B. It demonstrates 15-fold selectivity for binding BAZ2A/B over CECR2 and >100-fold selectivity over all other bromodomains.
|
Buy from Supplier |
N/A
|
BAZ2-ICR is a potent, selective, cell active and orally active BAZ2A/B bromodomains inhibitor with IC50s of 130 nM and 180 nM, and Kds of 109 nM and 170 nM, respectively. BAZ2-ICR shows 10-15-fold selectivity for
|
Buy from Supplier |